Evofem Biosciences Inc. buy krebskrebs
Start price
22.03.21
/
50%
€34.73
Target price
22.03.22
€52.50
Performance (%)
-84.26%
End price
23.03.22
€5.47
Summary
This prediction ended on 23.03.22 with a price of €5.47. The BUY prediction by krebskrebs for Evofem Biosciences Inc. performed very badly with a performance of -84.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evofem Biosciences Inc. | - | - | - | - |
iShares Core DAX® | 1.454% | 0.904% | 16.592% | 16.557% |
iShares Nasdaq 100 | -0.913% | 3.463% | 36.062% | 50.205% |
iShares Nikkei 225® | 2.355% | 3.830% | 14.881% | 10.110% |
iShares S&P 500 | 0.283% | 2.639% | 29.599% | 44.509% |
Comments by krebskrebs for this prediction
In the thread Evofem Biosciences diskutieren
Buy mit Kursziel 3,5
In the thread Trading Evofem Biosciences
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten